International Stem Cell Corporation Signed a Clinical Service Agreement With … – CNNMoney
|
International Stem Cell Corporation Signed a Clinical Service Agreement With …
CNNMoney International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a clinical stage biotechnology company developing novel stem cell-based therapies, announced today that it has entered into a master clinical research agreement with the … |
